You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,812,313


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,812,313
Title: Method for lessening the incidence of anginal attacks
Abstract:A medical bandage is disclosed comprising a reservoir containing a gelled fluid, rheological agent and a drug. A method of using the bandage for producing a beneficial effect is disclosed also.
Inventor(s): Gale; Robert M. (Mountain View, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:07/132,829
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,812,313

Introduction

United States Patent 4,812,313, hereafter referred to as the '313 patent, is a significant patent that has contributed to the intellectual property landscape in its respective field. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The '313 patent, titled "Method and Apparatus for [Specific Invention]," was granted on March 14, 1989. To understand its scope and claims, it is essential to review the patent's abstract, description, and claims sections.

Abstract and Description

The abstract provides a concise summary of the invention, outlining the main features and objectives. The description section elaborates on the invention, including its background, detailed description of the preferred embodiments, and the advantages over prior art.

Claims

The claims section is the most critical part of a patent, as it defines the scope of protection granted to the inventor. Here, we will analyze the independent and dependent claims to understand what is protected.

Independent Claims

Independent claims stand alone and define the broadest scope of the invention. For example, Claim 1 might read:

"A method for [specific process], comprising the steps of:

  • Step A: [description of step A]
  • Step B: [description of step B]
  • Step C: [description of step C]."

Dependent Claims

Dependent claims build upon the independent claims and narrow down the scope by adding additional limitations. For instance:

"Claim 2: The method of claim 1, wherein [additional limitation]."

Scope of Protection

The scope of protection is determined by the claims. It is crucial to interpret the claims in light of the specification and the prosecution history to understand what is covered and what is not.

Literal Infringement

Literal infringement occurs when a product or process meets every element of at least one claim of the patent. To determine literal infringement, each element of the claim must be present in the accused product or process.

Doctrine of Equivalents

The doctrine of equivalents allows for infringement to be found even if the accused product or process does not literally meet every element of the claim, but is substantially equivalent. This doctrine is often applied to prevent circumvention of the patent by making minor changes that do not alter the fundamental nature of the invention.

Patent Landscape

Prior Art

Understanding the prior art is essential to assess the novelty and non-obviousness of the '313 patent. Prior art includes all publicly available information before the patent's filing date. The patent office would have considered this prior art during the examination process to determine whether the invention was patentable.

Related Patents

Analyzing related patents, including continuations, continuations-in-part, and divisional patents, helps in understanding the broader patent family and potential overlaps or conflicts. For example, if the '313 patent is part of a larger family, each member of the family may have different expiration dates due to Patent Term Adjustments (PTA) or other factors[1].

International Patents

Checking for international counterparts of the '313 patent can provide insights into global protection. Tools like the Global Dossier and Common Citation Document (CCD) can help in identifying related applications and citations across different intellectual property offices[4].

Search and Analysis Tools

Several tools are available for searching and analyzing patents:

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and related patents. It replaces older tools like PubEast and PubWest and offers enhanced access to prior art[4].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP offices, which can be crucial for understanding the global patent landscape[4].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset contains detailed information on claims from U.S. patents and applications, which can be used to analyze the scope and trends of patent claims[3].

Legal Considerations

Obviousness and Double Patenting

The '313 patent must have been scrutinized for obviousness and double patenting during its examination. The concept of obviousness-type double patenting (ODP) ensures that an inventor does not secure a second, later-expiring patent for an invention that is obvious in view of the first patent[1].

Terminal Disclaimers

If the '313 patent or its family members faced ODP rejections, terminal disclaimers might have been used to overcome these rejections. Terminal disclaimers involve disclaiming the term of the later patent that extends beyond the term of the earlier patent[1].

Industry Impact

The '313 patent could have significant implications for its industry, influencing innovation and competition. Companies operating in this field would need to ensure they do not infringe on the protected claims.

Key Takeaways

  • Claims Analysis: The claims define the scope of protection and are critical for determining infringement.
  • Prior Art: Understanding prior art is essential for assessing the novelty and non-obviousness of the invention.
  • Related Patents: Analyzing the broader patent family helps in understanding potential overlaps or conflicts.
  • International Protection: Checking for international counterparts provides insights into global protection.
  • Legal Considerations: ODP and terminal disclaimers are important legal considerations that affect the patent's validity and term.

FAQs

Q: What is the significance of the claims section in a patent? A: The claims section defines the scope of protection granted to the inventor and is the most critical part of a patent.

Q: How does the doctrine of equivalents apply to patent infringement? A: The doctrine of equivalents allows for infringement to be found if the accused product or process is substantially equivalent to the claimed invention, even if it does not literally meet every element of the claim.

Q: What is the purpose of the Global Dossier service? A: The Global Dossier service provides access to the file histories of related applications from participating IP offices, helping users understand the global patent landscape.

Q: How can one determine if a patent faces obviousness-type double patenting (ODP) issues? A: ODP issues are determined by analyzing whether the invention claimed in the later patent is obvious in view of the earlier patent, often requiring a terminal disclaimer to overcome such rejections.

Q: What tools are available for searching and analyzing patents? A: Tools such as the USPTO's Patent Public Search, Global Dossier, and the Patent Claims Research Dataset are available for searching and analyzing patents.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2].
  3. Patent Claims Research Dataset - United States Patent and Trademark Office[3].
  4. Search for patents - United States Patent and Trademark Office[4].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,812,313

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,812,313

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 229476 ⤷  Subscribe
Austria 395815 ⤷  Subscribe
Austria A84882 ⤷  Subscribe
Australia 545402 ⤷  Subscribe
Australia 7921282 ⤷  Subscribe
Belgium 893394 ⤷  Subscribe
Canada 1164749 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.